Common radionuclides used for radiometabolic therapy include 131I, 153Sm, 89Sr, 223Ra, and 90Y. In this chapter we will focus on therapeutic radiopharmaceuticals are employed for therapy of differentiated follicular thyroid carcinomas, for therapy of pheochromocytoma/paraganglioma/ neuroblastomas, for bone pain palliation, for radioimmunotherapy of lymphomas, for peptide radioreceptor therapy of neuroendocrine tumors, and for intra-arterial radioembolization of hypervascularized tumors of the liver.
CITATION STYLE
Orsini, F., Mazzarri, S., Puta, E., Guidoccio, F., Lorenzoni, A., & Mariani, G. (2017). Radiopharmaceuticals for therapy. In Nuclear Oncology: From Pathophysiology to Clinical Applications (pp. 99–113). Springer International Publishing. https://doi.org/10.1007/978-3-319-26236-9_34
Mendeley helps you to discover research relevant for your work.